PTBP1 promotes hematopoietic stem cell maintenance and red blood cell development by ensuring sufficient availability of ribosomal constituents

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Matilda Rehn - , University of Copenhagen, Novo Nordisk Foundation (Author)
  • Anne Wenzel - , University of Copenhagen, Novo Nordisk Foundation (Author)
  • Anne Katrine Frank - , University of Copenhagen, Novo Nordisk Foundation (Author)
  • Mikkel Bruhn Schuster - , University of Copenhagen, Novo Nordisk Foundation (Author)
  • Sachin Pundhir - , University of Copenhagen, Novo Nordisk Foundation (Author)
  • Nanna Jørgensen - , University of Copenhagen, Novo Nordisk Foundation (Author)
  • Kristoffer Vitting-Seerup - , University of Copenhagen (Author)
  • Ying Ge - , University of Copenhagen, Novo Nordisk Foundation (Author)
  • Johan Jendholm - , University of Copenhagen, Novo Nordisk Foundation (Author)
  • Magali Michaut - , University of Copenhagen, Novo Nordisk Foundation (Author)
  • Erwin M. Schoof - , University of Copenhagen, Novo Nordisk Foundation, Technical University of Denmark (Author)
  • Tanja Lyholm Jensen - , University of Copenhagen, Novo Nordisk Foundation (Author)
  • Nicolas Rapin - , University of Copenhagen, Novo Nordisk Foundation (Author)
  • Russell T. Sapio - , Rowan University (Author)
  • Kasper Langebjerg Andersen - , University of Copenhagen (Author)
  • Anders H. Lund - , University of Copenhagen (Author)
  • Michele Solimena - , Molecular Diabetology, University Hospital Carl Gustav Carus Dresden, TUD Dresden University of Technology, Max Planck Institute of Molecular Cell Biology and Genetics, German Center for Diabetes Research (DZD e.V.) (Author)
  • Martin Holzenberger - , Sorbonne Université (Author)
  • Dimitri G. Pestov - , Rowan University (Author)
  • Bo Torben Porse - , University of Copenhagen, Novo Nordisk Foundation (Author)

Abstract

Ribosomopathies constitute a range of disorders associated with defective protein synthesis mainly affecting hematopoietic stem cells (HSCs) and erythroid development. Here, we demonstrate that deletion of poly-pyrimidine-tract-binding protein 1 (PTBP1) in the hematopoietic compartment leads to the development of a ribosomopathy-like condition. Specifically, loss of PTBP1 is associated with decreases in HSC self-renewal, erythroid differentiation, and protein synthesis. Consistent with its function as a splicing regulator, PTBP1 deficiency results in splicing defects in hundreds of genes, and we demonstrate that the up-regulation of a specific isoform of CDC42 partly mimics the protein-synthesis defect associated with loss of PTBP1. Furthermore, PTBP1 deficiency is associated with a marked defect in ribosome biogenesis and a selective reduction in the translation of mRNAs encoding ribosomal proteins. Collectively, this work identifies PTBP1 as a key integrator of ribosomal functions and highlights the broad functional repertoire of RNA-binding proteins.

Details

Original languageEnglish
Article number110793
JournalCell reports
Volume39
Issue number6
Publication statusPublished - 10 May 2022
Peer-reviewedYes

External IDs

PubMed 35545054

Keywords

Keywords

  • CP: Molecular biology, CP: Stem cell research, hematopoietic stem cells, protein synthesis, PTBP1, red blood cell development, ribosome assembly